Gyre Therapeutics, Inc. financial statements
Gyre Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 116.59M | 10-K |
| Net income | USD 9.88M | 10-K |
| Cash and equivalents | USD 49.19M | 10-Q |
Gyre Therapeutics, Inc. financials on 6ix · Gyre Therapeutics, Inc. on 6ix